March 16 (Reuters) - Catalyst Pharmaceuticals Inc:
* CATALYST PHARMACEUTICALS REPORTS FOURTH QUARTER AND YEAR-END 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* Q4 GAAP EARNINGS PER SHARE $0.07
* SEES FY 2020 REVENUE $135 MILLION TO $155 MILLION
* Q4 EARNINGS PER SHARE ESTIMATE $0.10 -- REFINITIV IBES DATA
* REITERATES NET REVENUE GUIDANCE IN RANGE OF $135 MILLION TO $155 MILLION FOR FY 2020
* QTRLY REVENUES $30.1 MILLION VERSUS $500,000
* CATALYST PHARMACEUTICALS SAYS IN FACE OF CORONAVIRUS COVID-19 OUTBREAK, CO IS “WELL PREPARED & WELL-STOCKED” FOR ANY CONTINGENCIES Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.